Results 51 to 60 of about 1,869 (190)

CROSS NEUTRALIZATION OF SOME SNAKE VENOMS FROM AFRICA AND MIDDLE EAST BY VACSERA POLYVALENT SNAKE ANTISERA [PDF]

open access: yesJournal of the Egyptian Society of Parasitology
An extensive study of neutralization of lethality of two species of elapid, seven species ofgenus Viper, and two species of Macrovipera by VACSERA polyvalent snake antisera.The results showed that polyvalent snake venom antisera prepared by injecting ...
ABIR ELFIKY, SHERIF ELFEEL
doaj   +1 more source

Hepatotoxic effect of elapid venom-a rare manifestation: Case report. [PDF]

open access: yesJ Family Med Prim Care
ABSTRACT Snake bite is a neglected tropical disease affecting millions of people across the globe. The highest burden exists in South East Asia and Sub-Saharan Africa. Around 45900 deaths could be attributed to snake bites in India with 25% of these deaths occurring in children between age group of 5–14 years.
Chaudhuri PK   +6 more
europepmc   +4 more sources

Occurrence and evolution of cannibal behaviour in extant snakes

open access: yesBiological Reviews, Volume 101, Issue 2, Page 644-664, April 2026.
ABSTRACT Extant snakes (Serpentes) are a highly diverse group of squamate reptiles, which have independently evolved key morphological adaptations to consume a large variety of vertebrate and invertebrate prey. While these predator–prey interactions have been widely addressed by several studies, little is known regarding the occurrence of cannibal ...
Bruna B. Falcão   +2 more
wiley   +1 more source

Engineered nanoparticles bind elapid snake venom toxins and inhibit venom-induced dermonecrosis

open access: yesPLOS Neglected Tropical Diseases, 2018
Envenomings by snakebites constitute a serious and challenging global health issue. The mainstay in the therapy of snakebite envenomings is the parenteral administration of animal-derived antivenoms. Significantly, antivenoms are only partially effective in the control of local tissue damage. A novel approach to mitigate the progression of local tissue
Jeffrey O’Brien   +3 more
openaire   +6 more sources

Molecular Evolution and Phylogeny of Elapid Snake Venom Three-Finger Toxins [PDF]

open access: yesJournal of Molecular Evolution, 2003
Animal venom components are of considerable interest to researchers across a wide variety of disciplines, including molecular biology, biochemistry, medicine, and evolutionary genetics. The three-finger family of snake venom peptides is a particularly interesting and biochemically complex group of venom peptides, because they are encoded by a large ...
Fry, B.G.   +6 more
openaire   +5 more sources

DataSheet1_An immunoinformatic approach to assessing the immunogenic capacity of alpha-neurotoxins in elapid snake venoms.xlsx

open access: yes, 2023
Introduction: Most elapid snakes produce venoms that contain alpha-neurotoxins (α-NTXs), which are proteins that cause post-synaptic blockade and paralysis in snakebite envenoming.
Kae Yi Tan (3174875)   +3 more
core   +1 more source

Heterologous expression, protein folding and antibody recognition of a neurotoxin from the Mexican coral snake Micrurus laticorallis

open access: yesJournal of Venomous Animals and Toxins including Tropical Diseases, 2016
Background The cysteine-rich neurotoxins from elapid venoms are primarily responsible for human and animal envenomation; however, their low concentration in the venom may hamper the production of efficient elapid antivenoms.
Herlinda Clement   +5 more
doaj   +1 more source

Platelet Desialylation Is a Novel Mechanism and Therapeutic Target in Daboia siamensis and Agkistrodon halys Envenomation-Induced Thrombocytopenia

open access: yesMolecules, 2022
Venom-induced thrombocytopenia (VIT) is one of the most important hemotoxic effects of a snakebite, which is often associated with venom-induced consumptive coagulopathy (VICC).
Cheng Zhang   +8 more
doaj   +1 more source

Polymeric Nanoparticles for the Diagnosis and Treatment of Snakebite

open access: yesMacromolecular Chemistry and Physics, Volume 227, Issue 1, 15 January 2026.
Snakebite envenomation affects between 1.8 and 5.5 million people annually, many of whom suffer disabilities or even death. Current antivenoms are composed of plasma‐derived antibodies. However, there remains an underexplored opportunity to utilise polymer‐based nanoparticles.
Neil Prabhakar   +2 more
wiley   +1 more source

Differential destructive (non-clotting) fibrinogenolytic activity in Afro-Asian elapid snake venoms and the links to defensive hooding behavior

open access: yes, 2019
Envenomations by venomous snakes have major public health implications on a global scale. Despite its medical importance, snakebite has long been a neglected tropical disease by both governments and medical science.
Zdenek, Christina N.   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy